Company
ABEONA THERAPEUTICS INC.
ABEO · CIK 0000318306
Sale of 4,902 shares at $5.1556 per share.
Reporting Person Vasanthavada Madhav · Officer Title Chief Commercial Officer · Transaction Code S
Traded Sep 29, 2026 · Disclosed Sep 29, 2026
Source: SEC Form 4 · 0001493152-26-044971 · filed 2026-09-29 · View filing →
Sale of 6,727 shares at $5.1556 per share.
Reporting Person O'Malley Brendan M. · Officer Title SVP, Chief Legal Officer · Transaction Code S
Traded Sep 29, 2026 · Disclosed Sep 29, 2026
Source: SEC Form 4 · 0001493152-26-044972 · filed 2026-09-29 · View filing →
Sale of 9,191 shares at $5.1556 per share.
Reporting Person Vazzano Joseph Walter · Officer Title Chief Financial Officer · Transaction Code S
Traded Sep 29, 2026 · Disclosed Sep 29, 2026
Source: SEC Form 4 · 0001493152-26-044973 · filed 2026-09-29 · View filing →
Sale of 19,608 shares at $5.1556 per share.
Reporting Person Seshadri Vishwas · Officer Title Chief Executive Officer · Transaction Code S
Traded Sep 29, 2026 · Disclosed Sep 29, 2026
Source: SEC Form 4 · 0001493152-26-044974 · filed 2026-09-29 · View filing →
Sale of 15,000 shares at $5.8644 per share.
Reporting Person Alvino Mark · Transaction Code S
Traded Sep 1, 2026 · Disclosed Sep 1, 2026
Source: SEC Form 4 · 0001493152-26-041068 · filed 2026-09-01 · View filing →